Warsaw, September 2, 2025 – Simon J. Britsch has been appointed to the position of President of Bayer Poland in addition to his role as Chief Financial Officer for the East Europe region. His international experience and deep understanding of Bayer’s business make him well-positioned to support the company’s continued growth and transformation in East Europe.
With a 25-year tenure at Bayer, Simon brings a wealth of experience to his new role. His journey with the company began in 2000 as a trainee in Germany, where he demonstrated his potential. In 2009, he was appointed CFO for Bayer Vietnam, based in Ho Chi Minh City, and three years later, he took on managerial responsibilities within the commercial area of the Healthcare division in Beijing, China. After seven impactful years in Asia, Simon returned to Germany in 2016 to take on strategic leadership roles, including the establishment of Bayer’s global Enterprise Risk Management function.
In 2021, he embarked on another international assignment in Mumbai, where he served as the CFO for the South Asia region, overseeing financial operations including Bayer’s publicly listed entity in India.
Since July 2025, Simon is based in Poland where he is responsible for shaping Bayer’s financial direction across East Europe from the company’s Warsaw office.
"True innovation thrives where curiosity meets courage - where science is not merely a discipline but a true passion, and leadership is not defined by hierarchy but shared through purpose and vision. In today’s interconnected world, every voice matters, every idea counts, and together we shape the future. That is why I am proud to be a member of TeamBayer, committed to harnessing our collective potential in pursuit of our mission Health for All, Hunger for None" – said Simon J. Britsch.
Simon holds a degree in Business Administration from the University of Applied Sciences in Essen and a Master of Business Administration from Instituto de Empresa Business School in Madrid. He has further developed his leadership capabilities through executive management programs at Harvard Business School, where he is recognized as an alumnus.
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to
Contacts:
/// Aleksandra Mrowiec, Head of Communication CEE, Bayer Sp. z o.o.
E–mail: aleksandra.mrowiec@bayer.com
Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.